Hepatitis C Virus NS2/3 Processing Is Required for NS3 Stability and Viral RNA Replication von Welbourn, Sarah, Green, Robin, Gamache, Isabelle, Dandache, Serge, Lohmann, Volker, Bartenschlager, Ralf, Meerovitch, Karen, Pause, Arnim

Volltext

In Vitro Antiviral Activity and Cross-Resistance Profile of PL-100, a Novel Protease Inhibitor of Human Immunodeficiency Virus Type 1 von DANDACHE, Serge, SEVIGNY, Guy, YELLE, Jocelyn, STRANIX, Brent R, PARKIN, Neil, SCHAPIRO, Jonathan M, WAINBERG, Mark A, WU, Jinzi J

Volltext

PL-100, a novel HIV-1 protease inhibitor displaying a high genetic barrier to resistance: An in vitro selection study von Dandache, Serge, Coburn, Craig A, Oliveira, Maureen, Allison, Timothy J, Holloway, M. Katharine, Wu, Jinzi J, Stranix, Brent R, Panchal, Chandra, Wainberg, Mark A, Vacca, Joseph P

Volltext

Tissue culture drug resistance analysis of a novel HIV-1 protease inhibitor termed PL-100 in non-B HIV-1 subtypes von Asahchop, Eugene L., Oliveira, Maureen, Brenner, Bluma G., Martinez-Cajas, Jorge L., Toni, Thomas d’Aquin, Ntemgwa, Michel, Moisi, Daniela, Dandache, Serge, Stranix, Brent, Tremblay, Cecile L., Wainberg, Mark A.

Volltext